PromarkerD is a blood test that can diagnose and predict whether a patient will develop diabetic kidney disease.
A team of artificial intelligence researchers has developed a new deep-learning method to identify and segment tumours in medical images.
Mylan N.V. and Revance Therapeutics, Inc. announce a global collaboration and license agreement for the development and commercialization of a proposed biosimilar to BOTOX (onabotulinumtoxinA). BOTOX […]
Prometic announces that it has received orphan drug designation status for Inter-Alpha-Inhibitor-Proteins (IaIp) in the treatment of necrotizing enterocolitis by the US Food and Drug Administration (FDA).
MilliporeSigma introduces the Viresolve Barrier capsule filters to reduce the risk of bioreactor contamination. The filters are designed to remove viruses, mycoplasma and bacteria from cell culture media.